By MD Anderson Cancer Center | November 14, 2018Investigational Drug Shows Promising Results in Phase II Study of Aggressive, Fatal Blood Disorder
By MD Anderson Cancer Center | August 23, 2018Combination Immunotherapy Shrinks Melanoma Brain Metastases
By MD Anderson Cancer Center | April 16, 2018First-in-Human Clinical Trial of New Targeted Therapy Drug Reports Promising Responses for Multiple Cancers